The stem cell-specific intermediate filament nestin missense variation p.A1199P is associated with pancreatic cancer

4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The intermediate filament nestin is upregulated in stem/progenitor cells and cancers, and regulates cell proliferation, migration, invasion and stemness. The present study comparatively analyzed serial autopsies of Japanese patients (n=2,206; males, 1,225; females, 981; median, 80.7 years old; range, 33-104 years old) with malignant tumors of whole organs, with respect to the clinical information, and 5 single nucleotide polymorphisms of the nestin gene. p.A1199P associated with pancreatic cancer (odds ratio, 4.4; 95% confidence interval, 1.9-10.0, P=0.001) while it did not associate with malignant neoplasms in other organs. p.A1199P did not associate with precancerous lesions of the pancreas. Single nucleotide polymorphisms of nestin were not associated with sex, drinking, smoking, or body weight. In conclusion, the amino acid 1,199 of nestin is localized in the tail structure of the filament and polymerizes with other intermediate filament proteins. The present results suggest that missense variations of nestin affect pancreatic carcinogenesis in Japanese patients.

Cite

CITATION STYLE

APA

Matsuda, Y., Tanaka, M., Sawabe, M., Mori, S., Muramatsu, M., Mieno, M. N., … Arai, T. (2019). The stem cell-specific intermediate filament nestin missense variation p.A1199P is associated with pancreatic cancer. Oncology Letters, 17(5), 4647–4654. https://doi.org/10.3892/ol.2019.10106

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free